Sir,

Psoriasis is a chronic inflammatory disease of the skin and joints, which is now considered a systemic inflammatory disease with Th-1 cells, Th-17 cells, and inflammatory cytokines contributing to its pathogenesis. Similarly, chronic Th-1 inflammation is important to the pathophysiology of obesity, metabolic syndrome, diabetes, atherosclerosis, and myocardial infarction.\[[@ref1][@ref2]\] We conducted a cross-sectional study involving 100 patients clinically diagnosed with psoriasis and 100 controls diagnosed with tinea infection at Dermatology and Venereology Outpatient Department of Sir Sunder Lal Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India between July 2015 to June 2017. Inclusion criteria were age \>20 years, chronic plaque psoriasis of any severity (clinically diagnosed), erythrodermic and generalized pustular psoriasis. Exclusion criteria included isolated palmoplantar and scalp psoriasis, psoriatic arthritis, pregnancy, lactation, known case of ischemic heart disease, diabetes mellitus, hypertension, renal and liver failure, patients receiving any systemic therapy (retinoids, methotrexate, cyclosporine, biologicals), or phototherapy within 1 month and topical treatment within 1 week, smoking and alcoholism. The severity of psoriasis was measured on the basis of psoriasis area severity index (PASI) (\>10 as severe). Metabolic syndrome (MS) was diagnosed by the presence of three or more criteria of the National Cholesterol Education Program\'s Adult Treatment Panel III (NCEP-ATP III)\[[@ref3]\]: waist circumference ≥102 cm (40") in men or ≥88 cm (35") in women; blood pressure ≥130/85; fasting plasma glucose ≥100 mg/dL; HDL cholesterol \<40 mg/dL in men or \<50 mg/dL in women; triglycerides ≥150 mg/dL.

The characteristics of the cases and controls have been compared in [Table 1](#T1){ref-type="table"}. The duration of psoriasis in our patients ranged from 6 months to 23 years while the PASI score of the 100 patients with psoriasis ranged from 2 to 32.5. Based on modified NCEP-ATP III criteria, MS was diagnosed in 44% patients with chronic plaque psoriasis and 14% in controls (*P* \< 0.001) with an odds ratio (OR) = 2.509 with 95% confidence interval of 1.56--4.03. This was in accordance with the study by Gisondi *et al*.\[[@ref4]\] Among the components of the metabolic syndrome, the following were found to be significantly more common in cases than in controls: low HDL, elevated blood pressure both systolic and diastolic, high cholesterol, LDL and CRP levels. There was a significant association of MS with severity of psoriasis (*P* = 0.035, OR = 2.509). Although Gisondi *et al*. in a study of patients with psoriasis of longer than 6 months duration observed an increased occurrence of MS, they did not find any correlation of MS with the severity of psoriasis. Moreover, Langan *et al*. noted a similar relationship of severity of psoriasis to the presence of obesity, hypertension and elevated fasting blood sugar, and metabolic syndrome.\[[@ref5]\] However, they categorized the severity of disease based on the percentage of body surface area involved which might be a poor marker of the severity of inflammation.

###### 

Comparison of cases and controls

  Parameters                    Cases Mean±SD         Control Mean±SD       *P*
  ----------------------------- --------------------- --------------------- ---------
  Age (Years)                   38.28±12.161          37.81±10.941          0.774
  HbA1c                         5.872±2.2473          5.529±0.7749          0.151
  Waist circumference (cm)      93.69±9.396           92.90±6.625           0.493
   Male                         95.08±8.857           95.66±4.995           0.622
   Female                       88.15±9.664           85.44±4.353           0.203
  Triglycerides (mg/dL)         134.981±99.0762       118.290±47.3558       0.130
  HDL (mg/dL)                   43.036±10.6725        47.540±5.8247         \<0.001
   Male                         41.902±10.61          47.589±5.74           \<0.001
   Female                       47.570±9.91           47.407±6.13           0.945
  Systolic BP (mm of Hg)        130.10±15.503         122.26±10.089         \<0.001
  Diastolic BP (mm of Hg)       86.00±8.099           79.42±5.244           \<0.001
  Fasting blood sugar (mg/dL)   105.367±25.2061       104.430±34.0873       0.825
  Total cholesterol (mg/dL)     176.445±42.4754       155.020±31.0324       \<0.001
  LDL (mg/dL)                   110.947±38.7284       76.700±31.0768        \<0.001
  CRP\*                         3.000 (2.300-7.300)   2.400 (1.898-3.950)   \<0.001

\*Median; BP - blood pressure

Thus, we conclude that all patients of psoriasis should be screened for cardiovascular risk factors, in particular, MS at the disease onset irrespective of the disease severity.
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